| Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Confidence score
|
Ref.
|
| acc1901 |
CUL3 |
neddylation |
unclear |
human |
Lung Cancer |
H1299 |
MLN4924 |
Impairing |
5.0 |
31208947
|
| acc1902 |
CUL4A |
neddylation |
unclear |
human |
Lung Cancer |
H1299 |
MLN4924 |
Impairing |
5.0 |
31208947
|
| acc1903 |
CUL4B |
neddylation |
unclear |
human |
Lung Cancer |
H1299 |
MLN4924 |
Impairing |
5.0 |
31208947
|
| acc1904 |
CUL5 |
neddylation |
unclear |
human |
Lung Cancer |
H1299 |
MLN4924 |
Impairing |
5.0 |
31208947
|
| acc1905 |
LCK |
nitration |
Tyr394 |
mouse |
Lung Cancer |
Lewis |
ICB |
Impairing |
4.5 |
30232256
|
| acc1906 |
LCK |
nitration |
Tyr394 |
mouse |
Prostate Cancer |
|
ICB |
Impairing |
4.5 |
30232256
|
| acc1907 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Myeloma |
ARP-1 |
Bortezomib |
Impairing |
5.0 |
27924158
|
| acc1908 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Myeloma |
ANBL6 |
Bortezomib |
Impairing |
5.0 |
27924158
|
| acc1909 |
HSP27 |
phosphorylation |
Ser78 |
human |
Leukemia |
THP-1 |
Apigenin |
Impairing |
5.0 |
21364669
|
| acc1910 |
HSP27 |
phosphorylation |
Ser82 |
human |
Leukemia |
THP-1 |
Apigenin |
Impairing |
5.0 |
21364669
|
| acc1911 |
HSP27 |
phosphorylation |
Ser15 |
human |
Lung Cancer |
SK-MES-1 |
Dioscin |
Associated |
4.0 |
33061803
|
| acc1912 |
HSP27 |
phosphorylation |
Ser15 |
human |
Lung Cancer |
NCI-H520 |
Dioscin |
Associated |
4.0 |
33061803
|
| acc1913 |
IGF1R |
phosphorylation |
Tyr1135 |
human |
Sarcoma |
U2OS |
Mitoxantrone |
Impairing |
5.0 |
34110249
|
| acc1914 |
IGF1R |
phosphorylation |
Tyr1136 |
human |
Sarcoma |
U2OS |
Mitoxantrone |
Impairing |
5.0 |
34110249
|
| acc1915 |
IGF1R |
phosphorylation |
Tyr1135 |
mouse |
Sarcoma |
MCA205 |
Mitoxantrone |
Impairing |
5.0 |
34110249
|
| acc1916 |
IGF1R |
phosphorylation |
Tyr1136 |
mouse |
Sarcoma |
MCA205 |
Mitoxantrone |
Impairing |
5.0 |
34110249
|
| acc1917 |
IGF1R |
phosphorylation |
Tyr1135 |
mouse |
Sarcoma |
MCA205 |
Oxaliplatin |
Impairing |
5.0 |
34110249
|
| acc1918 |
IGF1R |
phosphorylation |
Tyr1136 |
mouse |
Sarcoma |
MCA205 |
Oxaliplatin |
Impairing |
5.0 |
34110249
|
| acc1919 |
IGF1R |
phosphorylation |
Tyr1135 |
mouse |
Breast Cancer |
AT3 |
Oxaliplatin |
Impairing |
5.0 |
34110249
|
| acc1920 |
IGF1R |
phosphorylation |
Tyr1136 |
mouse |
Breast Cancer |
AT3 |
Oxaliplatin |
Impairing |
5.0 |
34110249
|
| acc1921 |
IGF1R |
phosphorylation |
Tyr1135 |
mouse |
Lung Cancer |
TC1 |
Oxaliplatin |
Impairing |
5.0 |
34110249
|
| acc1922 |
IGF1R |
phosphorylation |
Tyr1136 |
mouse |
Lung Cancer |
TC1 |
Oxaliplatin |
Impairing |
5.0 |
34110249
|
| acc1923 |
IGFBP-3 |
phosphorylation |
Ser |
human |
Lung Cancer |
A549 |
Cisplatin |
Impairing |
5.0 |
36766747
|
| acc1924 |
IGFBP-3 |
phosphorylation |
Ser |
human |
Lung Cancer |
H1299 |
Cisplatin |
Impairing |
5.0 |
36766747
|
| acc1925 |
IRS1 |
phosphorylation |
Ser312 |
human |
Breast Cancer |
MCF7 |
anisomycin |
Associated |
3.0 |
15952059
|
| acc1926 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Breast Cancer |
Bcap37 |
Paclitaxel |
Enhancing |
5.0 |
17568189
|
| acc1927 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Ovarian Cancer |
OV2008 |
Paclitaxel |
Enhancing |
5.0 |
17568189
|
| acc1928 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Colorectal Cancer |
HCT116 |
Evista (Raloxifene·HCl) |
Associated |
4.0 |
28711499
|
| acc1929 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MDA-MB-231 |
Evista (Raloxifene·HCl) |
Associated |
4.0 |
28711499
|
| acc1930 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
SUM159 |
Evista (Raloxifene·HCl) |
Associated |
4.0 |
28711499
|
| acc1931 |
mTOR |
phosphorylation |
Ser2448 |
human |
Cervical Cancer |
HeLa |
angelicin |
Associated |
4.0 |
31602210
|
| acc1932 |
mTOR |
phosphorylation |
Ser2448 |
human |
Cervical Cancer |
SiHa |
angelicin |
Associated |
4.0 |
31602210
|
| acc1933 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Oral Cancer |
SAS |
Cisplatin |
Impairing |
5.0 |
33551310
|
| acc1934 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Oral Cancer |
GNM |
Cisplatin |
Impairing |
5.0 |
33551310
|
| acc1935 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Oral Cancer |
SAS |
Magnolol |
Associated |
4.0 |
33551310
|
| acc1936 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Oral Cancer |
GNM |
Magnolol |
Associated |
4.0 |
33551310
|
| acc1937 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Sarcoma |
Rh30 |
Celecoxib |
Associated |
4.0 |
21397587
|
| acc1938 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Sarcoma |
RH28 |
Celecoxib |
Associated |
4.0 |
21397587
|
| acc1939 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Sarcoma |
RD2 |
Celecoxib |
Associated |
4.0 |
21397587
|
| acc1940 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
PEITC |
Associated |
4.0 |
19437484
|
| acc1941 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
LNCaP |
PEITC |
Associated |
4.0 |
19437484
|
| acc1942 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
PEITC |
Associated |
4.0 |
19437484
|
| acc1943 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
LNCaP |
PEITC |
Associated |
4.0 |
19437484
|
| acc1944 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
PEITC |
Associated |
4.0 |
19437484
|
| acc1945 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
LNCaP |
PEITC |
Associated |
4.0 |
19437484
|
| acc1946 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MDA-MB-231 |
B12 |
Associated |
4.0 |
33774344
|
| acc1947 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Colorectal Cancer |
HCT116 |
B12 |
Associated |
4.0 |
33774344
|
| acc1948 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Colorectal Cancer |
SW480 |
B12 |
Associated |
4.0 |
33774344
|
| acc1949 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Pancreas Cancer |
L3.6pl |
B12 |
Associated |
4.0 |
33774344
|
| acc1950 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Thyroid Cancer |
NPA-87 |
Phenylmethimazole(C10) |
Associated |
4.0 |
17525119
|
